[
  {
    "My Clinical Question (condition: chemotherapy/immunotherapy hepatotoxicity)": "***"
  },
  {
    "My most current assessment of this problem can be found in the note dated": "{Today/***}"
  },
  {
    "In your clinical question, or current note, please include information on": {
      "Assessments": [
        {
          "Disease being treated and (suspected) offending agent": "***"
        },
        {
          "Was the offending agent stopped": "***"
        },
        {
          "Any preexisting (pretreatment) hepatic disease": "***"
        },
        {
          "HBV (pretreatment) screening results": [
            {
              "Hepatitis B surface antigen (HbSAg)": "***"
            },
            {
              "Hepatitis B core antibody (anti-HBc)": "***"
            },
            {
              "Total immunoglobulin (Ig) or IgG": "***"
            },
            {
              "Antibody to hepatitis B surface antigen (anti-HBs)": "***"
            }
          ]
        }
      ],
      "Diagnostics": {
        "Required": [
          {
            "CMP (AST, ALT, Bilirubin, Alk Phos)": "***"
          },
          {
            "GTT": "***"
          }
        ],
        "Optional": [
          {
            "HAV Ab": "***"
          },
          {
            "HBsAg": "***"
          },
          {
            "Anti-HBc": "***"
          },
          {
            "Anti-HBs": "***"
          },
          {
            "HCV Ab": "***"
          },
          {
            "CMV": "***"
          },
          {
            "Abdominal ultrasound": "***"
          },
          {
            "Abdominal CT": "***"
          }
        ]
      },
      "Clinical Pearls": [
        {
          "Additional information on chemotherapy-induced liver injury is available from the LiverTox, a collaborative effort of the Liver Disease Research Branch of the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) and the National Library of Medicine (NLM). LiverTox is a freely accessible website that provides continuously updated comprehensive and evidence-based information about the clinical features of liver injury from drugs, dietary supplements, and herbal products along with a complete and annotated list of references": "***"
        },
        {
          "Most hepatotoxic drug reactions are idiosyncratic and classified mechanistically either as immunologic (hypersensitivity) or metabolic": "***"
        },
        {
          "While the reaction to many chemotherapy drugs is manifested by hepatocellular injury, inflammation, and/or cholestasis, other agents cause endothelial damage or thrombosis leading to vascular complications such as hepatic veno-occlusive disease (VOD, also called hepatic sinusoidal obstruction syndrome [SOS])": "***"
        }
      ]
    }
  }
]
